cisapride has been researched along with Respiratory Sounds in 3 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Respiratory Sounds: Noises, normal and abnormal, heard on auscultation over any part of the RESPIRATORY TRACT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gastro-oesophageal reflux (GOR) has been implicated in such clinical phenomena as aspiration pneumonia, bronchospasm or wheezing, apnea, stridor, and hoarseness." | 5.29 | Gastro-oesophageal reflux and chronic respiratory disease in infants and children: treatment with cisapride. ( Olafsdottir, E, 1995) |
| " We present single-subject trials of two pediatric patients done to assess the effect of cisapride on symptoms arising from gastroesophageal reflux." | 5.07 | The single-subject randomized trial. A useful clinical tool for assessing therapeutic efficacy in pediatric practice. ( Issenman, RM; Langer, JC; Winthrop, AL, 1993) |
| "Gastro-oesophageal reflux (GOR) has been implicated in such clinical phenomena as aspiration pneumonia, bronchospasm or wheezing, apnea, stridor, and hoarseness." | 1.29 | Gastro-oesophageal reflux and chronic respiratory disease in infants and children: treatment with cisapride. ( Olafsdottir, E, 1995) |
| "Weight gain was significant and recurrent cough and wheeze disappeared." | 1.28 | New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up. ( Dab, I; Malfroot, A, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Langer, JC | 1 |
| Winthrop, AL | 1 |
| Issenman, RM | 1 |
| Olafsdottir, E | 1 |
| Malfroot, A | 1 |
| Dab, I | 1 |
1 trial available for cisapride and Respiratory Sounds
| Article | Year |
|---|---|
The single-subject randomized trial. A useful clinical tool for assessing therapeutic efficacy in pediatric practice.
Topics: Adult; Child; Child, Preschool; Cisapride; Gagging; Gastroesophageal Reflux; Humans; Infant; Male; P | 1993 |
2 other studies available for cisapride and Respiratory Sounds
| Article | Year |
|---|---|
Gastro-oesophageal reflux and chronic respiratory disease in infants and children: treatment with cisapride.
Topics: Anti-Ulcer Agents; Asthma; Child; Child, Preschool; Chronic Disease; Cisapride; Gastroesophageal Ref | 1995 |
New insights on gastro-oesophageal reflux in cystic fibrosis by longitudinal follow up.
Topics: Child, Preschool; Cisapride; Cough; Cystic Fibrosis; Female; Follow-Up Studies; Gastroesophageal Ref | 1991 |